| Literature DB >> 29710889 |
Kira J Weissman1, Cameron J Smith1, Ulf Hanefeld1, Ranjana Aggarwal1, Matthew Bycroft1, James Staunton1, Peter F Leadlay2.
Abstract
The production of genetically engineered polyketides depends critically on thioesterase activity for product release. In vitro studies with the thioesterase from the erythromycin polyketide synthase (PKS) have demonstrated that the ability of this enzyme to act as a universal decoupler is limited, but stereochemical variation is readily tolerated. Synthetic analogues with all four stereochemical configurations of the natural substrate's 2-methyl-3-hydroxy substitution pattern (1-4; X=p-nitrophenoxy) were substrates for the enzyme. © 1998 WILEY-VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany.Entities:
Keywords: Antibiotics; Biosynthesis; Erythromycin; Polyketide synthase; Thioesterase
Year: 1998 PMID: 29710889 DOI: 10.1002/(SICI)1521-3773(19980605)37:10<1437::AID-ANIE1437>3.0.CO;2-7
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336